116 related articles for article (PubMed ID: 2909741)
1. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
Wilson WR; Thompson LH; Anderson RF; Denny WA
J Med Chem; 1989 Jan; 32(1):31-8. PubMed ID: 2909741
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-selective antitumor agents. 1. Relationships between structure, redox properties and hypoxia-selective cytotoxicity for 4-substituted derivatives of nitracrine.
Wilson WR; Anderson RF; Denny WA
J Med Chem; 1989 Jan; 32(1):23-30. PubMed ID: 2909736
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
4. Reductive metabolism and hypoxia-selective toxicity of nitracrine.
Wilson WR; Denny WA; Stewart GM; Fenn A; Probert JC
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1235-8. PubMed ID: 3744944
[TBL] [Abstract][Full Text] [Related]
5. Selective toxicity of nitracrine to hypoxic mammalian cells.
Wilson WR; Denny WA; Twigden SJ; Baguley BC; Probert JC
Br J Cancer; 1984 Feb; 49(2):215-23. PubMed ID: 6696822
[TBL] [Abstract][Full Text] [Related]
6. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis".
Denny WA; Atwell GJ; Anderson RF; Wilson WR
J Med Chem; 1990 May; 33(5):1288-95. PubMed ID: 2329552
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-selective radiosensitization of mammalian cells by nitracrine, an electron-affinic DNA intercalator.
Roberts PB; Anderson RF; Wilson WR
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Apr; 51(4):641-54. PubMed ID: 3495509
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Cytotoxicity, DNA binding, cellular uptake, and metabolism.
Siim BG; Hicks KO; Pullen SM; van Zijl PL; Denny WA; Wilson WR
Biochem Pharmacol; 2000 Oct; 60(7):969-78. PubMed ID: 10974206
[TBL] [Abstract][Full Text] [Related]
10. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
[TBL] [Abstract][Full Text] [Related]
11. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
Bartoszek A; Konopa J
Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
[TBL] [Abstract][Full Text] [Related]
12. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
Pawlak JW; Pawlak K; Konopa J
Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
[TBL] [Abstract][Full Text] [Related]
13. Anaerobic incubation and mutagenicity of nitracrine analogues in Salmonella typhimurium.
Ferguson LR; Roberton AM; Turner PM
Mutagenesis; 1987 Jul; 2(4):253-7. PubMed ID: 3325754
[TBL] [Abstract][Full Text] [Related]
14. Diminished toxicity of C-1748, 4-methyl-9-hydroxyethylamino-1-nitroacridine, compared with its demethyl analog, C-857, corresponds to its resistance to metabolism in HepG2 cells.
Wiśniewska A; Niemira M; Jagiełło K; Potęga A; Swist M; Henderson C; Skwarska A; Augustin E; Konopa J; Mazerska Z
Biochem Pharmacol; 2012 Jul; 84(1):30-42. PubMed ID: 22484277
[TBL] [Abstract][Full Text] [Related]
15. The mode of action of cytotoxic and antitumor 1-nitroacridines. III. In vivo interstrand cross-linking of DNA of mammalian or bacterial cells by 1-nitroacridines.
Konopa J; Pawlak JW; Pawlak K
Chem Biol Interact; 1983 Feb; 43(2):175-97. PubMed ID: 6402315
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic activity of nitracrine derivatives in Salmonella typhimurium: relationship to drug physicochemical parameters, and to bacterial uvrB and recA genes and plasmid pKM101.
Ferguson LR; Denny WA; O'Rourke SM
Mutat Res; 1989 May; 223(1):13-22. PubMed ID: 2654627
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells.
Ferguson LR; van Zijl P
Mutat Res; 1988 Apr; 204(4):655-63. PubMed ID: 3352647
[TBL] [Abstract][Full Text] [Related]
18. Bis-bioreductive agents as hypoxia-selective cytotoxins: nitracrine N-oxide.
Wilson WR; Van Zijl P; Denny WA
Int J Radiat Oncol Biol Phys; 1992; 22(4):693-6. PubMed ID: 1544839
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
20. The reaction between nitracrine and glutathione: implications for hypoxic cell radiosensitization and cytotoxicity.
Wilson WR; Anderson RF
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1001-5. PubMed ID: 2703377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
